Trial Profile
Phase III clinical study of AFT-801 (confirmatory study) Double-blind, placebo-controlled study for excessive daytime sleepiness accompanying obstructive sleep apnea syndrome in CPAP-treated patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Modafinil (Primary)
- Indications Sleep apnoea syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 03 Jun 2016 New trial record